Flucytosine: Updated recommendations for the use in patients with dihydropyrimidine dehydrogenase (DPD) deficiency
This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.
Referral - Article 31
Fluorouracil and fluorouracil related substances (capecitabine, tegafur and flucytosine) containing medicinal products
|Human ATC code||